4 Midcap High Margin Low Debt Quarterly Sales Growth Stocks to Watch for Future Multibagger Potential: NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma
- November 16, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
NALCO Rs 330. Sona BLW Rs 919. Navin Fluorine Rs 10,002. Ajanta Pharma Rs 3,284. Market caps from Rs 41,042 crore to Rs 60,609 crore. Data as of 13 Nov 2026.
Quick Answer
NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma are the 4 picks in this high margin low debt quarterly sales growth stocks watchlist, with market caps between Rs 41,042 crore and Rs 60,609 crore. NALCO stands out for the highest return on equity at 28.74%, while NALCO offers the lowest PE of the group at 8.47. PE ratios run from 8.47 to 77.73, so compare each one with its industry PE before investing. All figures are as of 13 November 2026.
High margin low debt quarterly sales growth stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma meet that test, with market caps from Rs 41,042 crore to Rs 60,609 crore and NALCO offering the highest return on equity at 28.74%. Each of these companies has an FY26 operating margin of at least 20 per cent, a debt-to-equity ratio below 0.3, latest-quarter revenue growth of at least 15 per cent year on year, a return on equity of at least 10 per cent, net profit growth in FY26 and in the latest quarter, and market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore.
This list covers high-margin companies with little debt and rising sales, ranked by market capitalisation. Every company has complete, verifiable financials, and investors screening high margin low debt quarterly sales growth stocks usually begin with size and balance sheet strength, so this list follows the same logic. All figures are as of 13 November 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are High Margin Low Debt Quarterly Sales Growth Stocks and Why Do They Attract Multibagger Interest?
High margin low debt quarterly sales growth stocks are shares of companies that clear several growth and quality tests at once: an FY26 operating margin of at least 20 per cent, a debt-to-equity ratio below 0.3 and latest-quarter revenue growth of at least 15 per cent year on year. The 4 here cover aluminium, auto components, pharmaceuticals and specialty chemicals.
A multi-year growth record together with a strong latest year and a rising latest quarter shows that demand for the business is steady and not a one-off spike. Within high margin low debt quarterly sales growth stocks, all 4 companies show rising profit in FY26 and in the latest quarter, which is the first check most investors make. With high margin low debt quarterly sales growth stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Anyone shortlisting high margin low debt quarterly sales growth stocks should compare valuation, growth and balance sheet strength together rather than relying on one number. Read each company’s latest results and exchange filings before acting on high margin low debt quarterly sales growth stocks. The figures for high margin low debt quarterly sales growth stocks in this article come from NSE and BSE data and company filings, and they are complete for every name shown. Within high margin low debt quarterly sales growth stocks, the common thread is rising profit backed by complete financial data. Track every result season for high margin low debt quarterly sales growth stocks, because earnings growth is what supports the share price over time. For high margin low debt quarterly sales growth stocks, a staggered approach across quarters helps manage valuation risk.
High Margin Low Debt Quarterly Sales Growth Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 13 November 2026. NALCO has the lowest PE of the group at 8.47, while NALCO posts the highest return on equity at 28.74%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | Debt to Equity |
|---|---|---|---|---|---|---|---|
| National Aluminium Company | 330 | 60,609 | 8.47 | 10.11 | 28.74% | 2.43 | 0.00 |
| Sona BLW Precision Forgings | 919 | 57,391 | 77.73 | 37.40 | 11.63% | 8.94 | 0.10 |
| Navin Fluorine International | 10,002 | 51,469 | 56.52 | 33.36 | 20.41% | 11.53 | 0.28 |
| Ajanta Pharma | 3,284 | 41,042 | 32.50 | 40.65 | 25.99% | 8.45 | 0.03 |
NALCO: 48.16% Operating Margin in FY26
National Aluminium Company is a government-owned producer of bauxite, alumina and aluminium with captive mines and a power plant. It reported FY26 revenue of Rs 18,508.88 crore, up 7.96% year on year, and net profit of Rs 5,797.01 crore, up 10.04%. Net profit has compounded at 18.38% a year since FY22, while revenue has grown 6.33% a year. Operating margin was 48.16% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the September 2026 quarter, revenue rose 27.54% to Rs 5,667.52 crore and net profit grew 28.33% to Rs 1,835.05 crore. Foreign investors raised their holding from 16.22% in September 2025 to 21.97% in September 2026. The stock trades at a PE of 8.47 against an industry PE of 10.11, below the sector average, with a return on equity of 28.74% and a price to book of 2.43.
Sona BLW: 25.91% Operating Margin in FY26
Sona BLW makes differential gears, motors and drive systems for electric and conventional vehicles for customers around the world. It reported FY26 revenue of Rs 4,572.11 crore, up 24.19% year on year, and net profit of Rs 629.19 crore, up 4.92%. Net profit has compounded at 14.86% a year since FY22, while revenue has grown 20.75% a year. Operating margin was 25.91% in FY26. The debt-to-equity ratio is 0.10, which keeps interest costs low.
In the September 2026 quarter, revenue rose 35.93% to Rs 1,577.37 crore and net profit grew 30.81% to Rs 222.99 crore. Domestic institutions raised their holding from 40.13% in September 2025 to 41.22% in September 2026. The stock trades at a PE of 77.73 against an industry PE of 37.40, with a return on equity of 11.63% and a price to book of 8.94.
Navin Fluorine: 34.41% Operating Margin in FY26
Navin Fluorine International makes specialty fluorochemicals, refrigerant gases and contract research and manufacturing services. It reported FY26 revenue of Rs 3,379.19 crore, up 41.20% year on year, and net profit of Rs 663.56 crore, up 129.92%. Net profit has compounded at 26.02% a year since FY22, while revenue has grown 22.66% a year. Operating margin was 34.41% in FY26. The debt-to-equity ratio is 0.28, which keeps interest costs low.
In the September 2026 quarter, revenue rose 55.33% to Rs 1,206.34 crore and net profit grew 81.47% to Rs 269.24 crore. Foreign investors raised their holding from 22.15% in September 2025 to 23.38% in September 2026. The stock trades at a PE of 56.52 against an industry PE of 33.36, with a return on equity of 20.41% and a price to book of 11.53.
Ajanta Pharma: 28.74% Operating Margin in FY26
Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.03, which keeps interest costs low.
In the September 2026 quarter, revenue rose 29.61% to Rs 1,831.55 crore and net profit grew 49.18% to Rs 388.14 crore. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026. The stock trades at a PE of 32.50 against an industry PE of 40.65, below the sector average, with a return on equity of 25.99% and a price to book of 8.45.
High Margin Low Debt Quarterly Sales Growth Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these high margin low debt quarterly sales growth stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Latest Quarter Profit Growth (YoY) |
|---|---|---|---|---|---|---|
| NALCO | 18,508.88 | 5,797.01 | 7.96% | 6.33% | 18.38% | 28.33% |
| Sona BLW | 4,572.11 | 629.19 | 24.19% | 20.75% | 14.86% | 30.81% |
| Navin Fluorine | 3,379.19 | 663.56 | 41.20% | 22.66% | 26.02% | 81.47% |
| Ajanta Pharma | 5,624.93 | 1,056 | 18.60% | 12.94% | 10.33% | 49.18% |
Check the Univest Screener for live data on these high margin low debt quarterly sales growth stocks
Institutional Holding in NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma
Institutional holding shows who is backing these high margin low debt quarterly sales growth stocks alongside the promoter. The table uses the latest reported quarter for each. Sona BLW has the deepest institutional backing, with FII and DII together holding 65.09% as of September 2026. Domestic institutions increased their holding over the past year in Sona BLW (from 40.13% to 41.22%) and Ajanta Pharma (from 17.90% to 21.94%). To see how this group fits the wider market, many investors compare it with the Nifty Midcap 100.
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| NALCO | 51.28% | 21.97% | 11.71% | 15.04% | September 2026 |
| Sona BLW | 27.91% | 23.87% | 41.22% | 7.00% | September 2026 |
| Navin Fluorine | 27.08% | 23.38% | 28.70% | 20.85% | September 2026 |
| Ajanta Pharma | 63.47% | 7.63% | 21.94% | 6.96% | September 2026 |
Risks to Weigh in High Margin Low Debt Quarterly Sales Growth Stocks
Being careful with high margin low debt quarterly sales growth stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Sona BLW trades at a PE of 77.73 against an industry PE of 37.40, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one theme, so size each position to match your risk appetite.
How to Choose Between High Margin Low Debt Quarterly Sales Growth Stocks
Picking from high margin low debt quarterly sales growth stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (10.11 to 40.65) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma live prices.
Conclusion
Among high margin low debt quarterly sales growth stocks, NALCO stands out for the highest return on equity at 28.74%, NALCO for the lowest PE of the group at 8.47, Navin Fluorine for the fastest profit compounding at 26.02% a year since FY22 and Navin Fluorine for the sharpest latest-quarter profit growth at 81.47%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high margin low debt quarterly sales growth stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on High Margin Low Debt Quarterly Sales Growth Stocks to Watch
Which are the best high margin low debt quarterly sales growth stocks to watch for multibagger potential?
Ans. NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 60,609 crore, Rs 57,391 crore, Rs 51,469 crore and Rs 41,042 crore respectively. NALCO is notable for the highest return on equity at 28.74%. NALCO stands out for the lowest PE of the group at 8.47. Navin Fluorine offers the fastest profit growth, 26.02% a year since FY22. Navin Fluorine brings the sharpest latest-quarter profit growth at 81.47%. These are watchlist names for high margin low debt quarterly sales growth stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is NALCO a good stock for long-term investors?
Ans. NALCO has a return on equity of 28.74%, a PE of 8.47 against an industry PE of 10.11 and a market cap of Rs 60,609 crore. Net profit has compounded at 18.38% a year since FY22, and FY26 revenue rose 7.96% while September 2026 quarter net profit grew 28.33%. Long-term returns in high margin low debt quarterly sales growth stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Navin Fluorine become a multibagger from here?
Ans. A multibagger outcome in high margin low debt quarterly sales growth stocks requires earnings to keep growing faster than the market for several years. Navin Fluorine has grown revenue at 22.66% a year since FY22 and net profit at 26.02% a year, and FY26 revenue rose 41.20%. At a PE of 56.52 against an industry PE of 33.36, valuation should be checked against that growth before investing, and no outcome is guaranteed.
What is the market cap of NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma?
Ans. As of 13 November 2026, NALCO has a market cap of Rs 60,609 crore, Sona BLW has a market cap of Rs 57,391 crore, Navin Fluorine has a market cap of Rs 51,469 crore and Ajanta Pharma has a market cap of Rs 41,042 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high margin low debt quarterly sales growth stocks.
What are the risks of investing in high margin low debt quarterly sales growth stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Sona BLW trades at a PE of 77.73 against an industry PE of 37.40, so earnings growth needs to hold up. Diversifying across the 4 names and reviewing each quarterly result helps keep risk in check.
Why is Sona BLW trading at a PE of 77.73?
Ans. Sona BLW’s PE of 77.73 compares with an industry PE of 37.40. The market is paying a premium for a return on equity of 11.63%, profit growth of 14.86% a year since FY22 and latest-quarter profit growth of 30.81%, which also means the stock is more sensitive if growth slows. Investors in high margin low debt quarterly sales growth stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in NALCO, Sona BLW, Navin Fluorine and Ajanta Pharma?
Ans. As of the latest reported quarter, FII and DII together hold 33.68% of NALCO (21.97% and 11.71%), 65.09% of Sona BLW (23.87% and 41.22%), 52.08% of Navin Fluorine (23.38% and 28.70%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in high margin low debt quarterly sales growth stocks, though it should be read with earnings trends rather than on its own.